Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cholic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115536720A details a novel chemical synthesis for cholic acid intermediate A8, offering a virus-free, plant-based alternative to animal extraction with scalable manufacturing potential.
Patent CN116249536A reveals a novel batch production method for sodium taurodeoxycholate using isopropanol purification, offering high purity and simplified manufacturing for reliable supply chains.
Novel silylation technology for UDCA purification offers high selectivity and reduced solvent consumption for pharmaceutical intermediate manufacturing supply chains.
Patent CN102718829B reveals high-yield TUDCA synthesis avoiding ion-exchange columns ensuring cost reduction and supply reliability for global pharmaceutical intermediates
Patent CN115611961B enables safe chemical synthesis of cholic acid intermediates reducing viral risks and ensuring supply chain stability for global pharmaceutical manufacturers.
Novel patent CN105315320B details improved Obeticholic Acid synthesis with enhanced yield and safety for reliable pharmaceutical intermediates supplier partnerships.
Patent CN112898368B reveals Pd-catalyzed route for obeticholic acid intermediate, offering mild conditions and supply chain stability for pharma manufacturing.
Patent CN104876995B details a 5-step Swern oxidation route for 6ECDCA. Offers high purity, reduced waste, and scalable manufacturing for global supply chains.
Patent CN106046095B reveals mild Obeticholic acid synthesis. Eliminates LDA cryogenic steps. Enables cost reduction in pharmaceutical intermediates manufacturing.
Patent CN113480589B details a novel DMAP salt method for UDCA purification ensuring high yield and purity for reliable pharmaceutical intermediate supply chains.
Patent CN121085987A reveals scalable synthesis for 5 beta-carp cholesterol sulfate. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN114592027A reveals a novel two-step method for Tauroursodeoxycholic Acid production, offering significant cost reduction in API manufacturing and high-purity outcomes.
Discover a novel high-yield synthesis for Obeticholic Acid intermediates via Weinreb amide protection. Enhance purity to 99.9% and reduce manufacturing costs significantly.
Patent CN114958699A reveals a novel dual-enzyme co-expression strategy for ursodeoxycholic acid, offering superior purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN106831923B reveals a novel CDCA synthesis route. Discover high-purity manufacturing, supply chain reliability, and significant cost reduction strategies.
Patent CN115651049A details a synthetic route for Cholic Acid Intermediate A3, offering a virus-free alternative to animal extraction for reliable pharmaceutical supply chains.
Patent CN114181274B reveals a novel mixed-base catalyzed method for stable enolization and ethylidene reactions, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN105481925A reveals a novel catalytic transfer hydrogenation route for high-purity Obeticholic Acid intermediates, ensuring supply chain reliability.
Patent CN118388570A reveals a novel enzymatic-chemical hybrid route for UDCA intermediates. Achieve superior selectivity and safety for pharmaceutical manufacturing.
Patent CN115536720B reveals plant-based cholic acid intermediate synthesis. Eliminates animal extraction risks. Offers scalable pharmaceutical intermediates manufacturing solutions.